USPTO serial 79293682
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and veterinary products, namely, pharmaceutical products and medications made of peptides for inducing protein aggregation in the treatment of cancer and infectious diseases and synthetic peptides as pharmaceutical products and medications for inducing protein aggregation in the treatment of cancer and infectious diseases; all of the foregoing commercialized through a select network of clinicians who administer the products and medications in a hospital setting or available through prescription by a clinician | ACTIVE | — |
| 042 | Scientific and technological services and research and design relating thereto, namely, pharmaceutical research and development of peptide-based pharmaceutical products and medicines and pharmaceutical research and development of pharmaceutical products and medicines on the basis of protein aggregation stimulating peptides | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 4, 2025 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 16, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 16, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 15, 2023 | MAB3 | ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL | — |
| Dec 15, 2023 | MAB3 | ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL | — |
| Dec 14, 2023 | ABN3 | ABANDONMENT - AFTER EX PARTE APPEAL | — |
| Dec 14, 2023 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Oct 30, 2023 | EXFB | EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF | — |
| Aug 16, 2023 | GEA1 | NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED | — |
| Aug 16, 2023 | GECD | ACTION DENYING REQ FOR RECON E-MAILED | — |
| Aug 16, 2023 | CNCF | ACTION CONTINUING FINAL - COMPLETED | — |
| Nov 18, 2022 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Apr 2, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 1, 2022 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 1, 2022 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 1, 2022 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 13, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Feb 23, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 23, 2022 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jan 26, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 26, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 26, 2022 | ALIE | ASSIGNED TO LIE | — |
| Jan 21, 2022 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jan 20, 2022 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Jan 20, 2022 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Jan 20, 2022 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Jul 30, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 30, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 30, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 4, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 26, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 26, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 26, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 2, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 6, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 13, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 13, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 27, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 26, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 22, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 29, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 25, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 22, 2020 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Sep 17, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |